Alström Syndrome International
Alström Syndrome International is a 501(c)(3) nonprofit that supports families and advances research for the ultra-rare Alström Syndrome across 47 countries, managing the world's largest clinical database of 900+ patients and coordinating clinical guidelines, conferences, and global regional partner organizations.
- Company typePrivate
- Founded1995
- HeadquartersMount Desert, United States
- Headcount—
- GTM typeB2C
- OfferingServices
What Alström Syndrome International does
Alström Syndrome International (ASI) is a 501(c)(3) nonprofit organization founded in 1995 and headquartered in Burleson, Texas, that supports individuals affected by Alström Syndrome — an ultra-rare genetic condition (prevalence approximately 1 in 514,000) caused by mutations in the ALMS1 gene affecting vision, hearing, cardiac function, metabolism, and other systems. The organization serves a global community across 47 countries representing every ethnicity, anchored by a six-person staff led by Executive Director Rocky Tucker and Science Director Chase A. Palmer, supported by a board of directors, Family Support Coordinators, and a network of 11 affiliated regional partner organizations spanning North America, South America, Europe, Asia, and Africa.
ASI's core service portfolio includes the Alström Syndrome Patient Registry, the ASI Handbook, evidence-based clinical monitoring guidelines, specialized pediatric and adult clinics held at partner hospitals (Golisano Children's Hospital and Riley Children's Health), biennial international Family Conferences & Scientific Symposia, Family Support Services, a Sibling Circle Program, and the world's largest Alström clinical database containing data from more than 900 individuals. In December 2025, ASI formalized two strategically significant partnerships: a data collection initiative with RARE-X (Global Genes) enabling patient-owned structured research data, and a research collaboration with Alstara, a biotech focused on Alström treatment development. Research collaborations also extend to The Jackson Laboratory (Naggart Lab) and international medical centers in Italy, Canada, the UK, and Sweden.
The organization operates as a community-led nonprofit with no commercial products or services sold. Revenue is generated entirely through individual donations, annual fundraising campaigns (including a current $1 Million Total Fundraising Goal for the Annual Fund Drive), and grants and philanthropy from foundations and partner organizations including the Chan Zuckerberg Initiative, NORD, EURORDIS, and Genetic Alliance. ASI's go-to-market is direct engagement rather than traditional sales channels, reaching families and professionals through its website, social media, newsletters, conferences, and curated peer-support networks including a private Facebook group.
Alström Syndrome International firmographics
Firmographics- Name
- Alström Syndrome International
- Legal name
- Alström Syndrome International
- Website
- https://alstrom.org
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Short description
- Alström Syndrome International is a 501(c)(3) nonprofit that supports families and advances research for the ultra-rare Alström Syndrome across 47 countries, managing the world's largest clinical database of 900+ patients and coordinating clinical guidelines, conferences, and global regional partner organizations.
- Ownership category
- akta.pro rank
Where Alström Syndrome International is headquartered
LocationHeadquarters
- HQ city
- Mount Desert
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Alström Syndrome International business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Individual Donations: Individual donors contribute tax-deductible donations to support ASI's mission of providing support, information, and coordination worldwide to families and professionals treating Alström Syndrome while working toward a cure.
- Fundraising Campaigns: Annual Fund Drive campaigns and special fundraising events like Boots & BBQ For a Cure generate revenue. Current campaign aims for $1 Million total fundraising goal.
- Grants and Philanthropy: Secures funding through grants, corporate partnerships, and annual giving programs from foundations and organizations supporting rare disease research.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Alström Syndrome International product offering
Product offeringCore offering
Alström Syndrome International (ASI) is a 501(c)(3) nonprofit organization that supports individuals and families affected by Alström Syndrome and advances clinical and translational research toward a cure. Its core offerings comprise family support services, educational resources (ASI Handbook, Monitoring Guidelines), the world's largest Alström Clinical Database, the Patient Registry and RARE-X Data Collection Program, specialized pediatric and adult Clinical Clinics, and biennial Family Conference & Scientific Symposiums. ASI operates across 47 countries and has no commercial products; all services are delivered free of charge to families and clinicians.
Product overview
Alström Syndrome International (ASI) operates as a nonprofit patient advocacy and research coordination organization rather than a commercial software product company. Its offerings comprise a suite of service programs: the Alström Syndrome Patient Registry enabling data contribution for research; the ASI Handbook providing comprehensive disease management guidance; the RARE-X Data Collection Program powering patient-owned research data collection; biennial Family Conference & Scientific Symposium events; specialized Clinical Clinics at partner hospitals; Family Support Services coordinated by support coordinators; the world's largest Alström Syndrome Clinical Database with data from over 900 individuals; Sibling Circle support for siblings; Visually Impaired Resources; and Monitoring Guidelines for clinicians. These services work together to support families, advance research, and accelerate progress toward treatments and a cure.
Differentiator
Problem solved
Functional benefit
Products and services
- Alström Syndrome Patient Registry A patient registry program allowing individuals with Alström Syndrome to contribute their health data to accelerate research and drug development, enabling participation in clinical trials and supporting the global research community.
- RARE-X Data Collection Program A patient-owned data collection initiative powered by the RARE-X technology platform that enables Alström families to contribute research-ready data in a phased approach, accelerating research and clinical trial development while preserving family governance, consent, and data security.
- ASI Family Conference & Scientific Symposium A biennial international event bringing together families, researchers, clinicians, and advocates for connection, education, and research advancement, including scientific presentations, family activities, and stakeholder meetings.
- Alström Syndrome Clinical Clinics Specialized pediatric and adult clinics held at partner hospitals that bring together medical professionals experienced with Alström Syndrome, offering personalized care, stakeholder meetings, and family networking opportunities.
- Family Support Services A coordinated network of Family Support Coordinators providing guidance, connecting families with medical specialists, facilitating access to the private Facebook group, and keeping families informed about research advances and upcoming events.
- Alström Syndrome Clinical Database The world's largest Alström clinical database containing information from more than 900 individuals worldwide, supporting research collaborations and providing essential data for understanding the disease.
- ASI Handbook A comprehensive handbook providing expert information, guidance, and tools for navigating life with Alström Syndrome, covering diagnosis, management, and treatment of the condition.
- Monitoring Guidelines Evidence-based clinical management guidelines for monitoring and treating Alström Syndrome, including recommended tests and examinations across multiple organ systems (vision, hearing, cardiac, hepatic, endocrine, renal, and others).
- Sibling Circle Program A support program specifically designed for siblings of individuals with Alström Syndrome, providing resources, community connections, and support coordination to help siblings navigate the challenges of having a sibling with a rare disease.
Quantifiable outcome
- Patient database covering 900+ individuals worldwide
- +2 more outcomes
Companies that use Alström Syndrome International
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Alström Syndrome International technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Alström Syndrome International partnerships and signals
Strategic signalPartnerships
24 partnerships are on record, tiered core and supporting.
- RARE-X (Global Genes)coreThe Alström Syndrome community is partnering with RARE-X, a program of Global Genes, to build a Data Collection Program. This patient-owned data initiative will help accelerate research and the development of new drugs, devices, and therapies. The RARE-X technology platform enables structured data collection while families maintain governance, consent, and data security.
- AlstaracoreNew partnership announced in December 2025 Research & Science Update. Alstara is a research partner contributing to ASI's powerful roadmap for research efforts over the next several years.
- Sheraton Downtown Fort Worth HotelsupportingHost hotel and sponsor for the 11th ASI Family Conference & Scientific Symposium. Located at 1701 Commerce Street, Fort Worth, TX 76102. Provides conference venue and accommodation for attendees.
- Genetic AlliancesupportingPartner organization strengthening research and advocacy for rare disease community
- National Organization for Rare Disorders (NORD)supportingPartner organization supporting rare disease advocacy and patient interests
- EURORDISsupportingEuropean rare disease organization partner for international advocacy collaboration
- The Jackson LaboratorycoreResearch partner providing Fat Aussie mouse models used in Alström research. Located in Bar Harbor, ME. The Naggert Lab at JAX conducts Alström-related research.
- Riley Children's Health at IU HealthcoreMedical center partner hosting Adult Clinic and Stakeholder Meeting in Indianapolis, Indiana
- Golisano Children's HospitalcoreMedical center partner hosting Pediatric Clinic and Stakeholder Meeting in Rochester, NY
- University School of Medicine, Padua, ItalysupportingInternational research and medical center collaborating on Alström Syndrome research efforts
- The Hospital for Sick Children, Toronto, CanadasupportingInternational pediatric research center partner for Alström research collaboration
- Birmingham Children's Hospital, UKsupportingUK-based pediatric hospital partner for international research efforts
- Swedish Institute for Disability Research, Örebro University HospitalsupportingScandinavian research partner contributing to Alström Syndrome research and clinical understanding
- Alström Syndrome UKsupportingRegional partner organization based at 31 Shearwater Drive, Torquay, Devon TQ2 7TL. Led by CEO Ann Chivers. Serves Alström families in the United Kingdom.
- Alström Syndrome AustraliasupportingRegional partner organization serving Alström families in Australia through Facebook community
- ASI BrazilsupportingRegional partner serving Brazilian families at SMPW quadra 17 conjunto 7 Lote 1 casa G, Park Way, Brasilia-DF, CEP: 71741-707, Brasil
- Alström Syndrome CanadasupportingRegional partner serving Canadian families. Contact: Linda Holland and Palmer Douglas
- ASI Deutschland (Germany)supportingRegional partner in Germany. Contact: Dr. med. Sebastian Beck, Kinderarztpraxis im Blauen Haus, Hauptstr. 138, CH-8280 Kreuzlingen
- France AlströmsupportingRegional partner in France at 70 bis rue du Général de Gaulle 95, 370 Montigny Les Cormeilles
- ASSAI - Associazione Sindrome di Alström ItaliasupportingItalian national association serving Alström families in Italy
- Alström Syndrome JapansupportingRegional partner in Japan at 5-23 Karasubashichou Fushimiku Daigo Kyoto, Japan 601-1315
- Stichting Alström Syndroom (Netherlands)supportingDutch foundation serving Alström families in the Netherlands
- Alström SpainsupportingRegional partner in Spain serving Spanish-speaking Alström families
- Alström Sendromu Dernegi (Turkey)supportingTurkish national association at Abant Izzet Baysal Üniversitesi Dekanlik Binasi 2.kat Gölköy Bolu, Turkey
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Alström Syndrome International competitors and assessment
Company assessmentBroad incumbents
- National Organization for Rare Disorders (NORD): Umbrella advocacy organization representing hundreds of rare disease patient groups including ASI; provides shared advocacy, policy, and research infrastructure for the broader community.
- Global Genes: Allied rare disease advocacy organization that operates the RARE-X data platform used by ASI; comparable mission at a broader cross-disease level.
- EURORDIS - Rare Diseases Europe: European umbrella for rare disease patient organizations; ASI's listed international partner that coordinates cross-border advocacy and rare disease policy in Europe.
Direct peers
- Cystinosis Research Foundation: Ultra-rare disease-specific nonprofit that funds research, supports affected families, and convenes researchers/clinicians globally — same structural model as ASI, applied to cystinosis.
- Cystic Fibrosis Foundation: Patient-founded nonprofit that supports families affected by a single rare genetic disease, funds a global research/clinical trials network, and operates a patient registry — directly analogous to ASI's model for Alström Syndrome.
- Foundation for Prader-Willi Research: Single-disease rare disease nonprofit funding research, running patient registries, and hosting scientific/family conferences — directly mirrors ASI's three-pillar model (family support, education, research).
- The Marfan Foundation: Rare genetic disease nonprofit providing family support, clinical management guidelines, and a patient registry — similar mission, similar GTM (community-led, multi-channel engagement).
Regional players
- Alström Syndrome Canada: Canadian regional counterpart serving Alström families locally; operates under ASI's regional partner network with comparable mission but narrower geographic scope.
- Alström Syndrome UK: Sister organization supporting Alström families in the United Kingdom; serves the same patient population as ASI but in a different geography, listed as ASI's regional channel partner.
Others
- RARE-X: Federated patient-owned data collection platform (a program of Global Genes) that ASI uses to power its data collection program; an ecosystem enabler rather than a peer advocacy organization.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights7 records
Customer concentration
Alström Syndrome International social profiles
Digital presenceAlström Syndrome International financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alström Syndrome International leadership team
Management profileNumber of profiles
Profiles21 records
Alström Syndrome International funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alström Syndrome International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alström Syndrome International
What does Alström Syndrome International do?
Alström Syndrome International (ASI) is a 501(c)(3) nonprofit organization that supports individuals and families affected by Alström Syndrome and advances clinical and translational research toward a cure. Its core offerings comprise family support services, educational resources (ASI Handbook, Monitoring Guidelines), the world's largest Alström Clinical Database, the Patient Registry and RARE-X Data Collection Program, specialized pediatric and adult Clinical Clinics, and biennial Family Conference & Scientific Symposiums. ASI operates across 47 countries and has no commercial products; all services are delivered free of charge to families and clinicians.
Is Alström Syndrome International a public or private company?
Alström Syndrome International is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Alström Syndrome International founded?
Alström Syndrome International was founded in 1995.
Where is Alström Syndrome International based?
Alström Syndrome International is headquartered in Mount Desert, United States, in the North America region.
How does Alström Syndrome International make money?
Three revenue lines are on record. Individual Donations are the primary driver. The others are fundraising Campaigns and grants and Philanthropy.
Who are Alström Syndrome International's main competitors?
Broad incumbents on record are National Organization for Rare Disorders (NORD), Global Genes and EURORDIS - Rare Diseases Europe. Direct peers are Cystinosis Research Foundation, Cystic Fibrosis Foundation, Foundation for Prader-Willi Research and The Marfan Foundation. Regional players are Alström Syndrome Canada and Alström Syndrome UK. RARE-X is listed as an others.
Does Alström Syndrome International have an API?
No public API is recorded for Alström Syndrome International.